Back to People Listing
Affiliate Faculty

Herbert Lyerly

Professor of Surgery
Assistant Professor in Immunology
Associate Professor of Pathology

(919) 681-8350
lyerl001@mc.duke.edu

Visit Website

Herbert Lyerly

Summary

Clinical Interests:

Surgical treatment of breast cancer; gene- and immune-based therapy for breast, kidney, lung, colon, and pancreatic cancers

Recent Publications

Quiroga, D, Lyerly, HK, and Morse, MA. "Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer." Current treatment options in oncology 17, no. 8 (August 2016): 41-. (Review)

Vaidyanathan, G, McDougald, D, Choi, J, Koumarianou, E, Weitzel, D, Osada, T, Lyerly, HK, and Zalutsky, MR. "Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET." Journal of nuclear medicine : official publication, Society of Nuclear Medicine 57, no. 6 (June 2016): 967-973.

Oldham, M, Yoon, S, Meng, B, Fathi, Z, Beyer, W, Adamson, J, Alcorta, D, Osada, T, Lyerly, K, Dewhirst, M, Fecci, P, Walder, H, and Spector, N. "WE-FG-BRA-01: Cancer Treatment Utilizing Photo-Activation of Psoralen with KV X-Rays." Medical physics 43, no. 6 (June 2016): 3823

Price, TT, Burness, ML, Sivan, A, Warner, MJ, Cheng, R, Lee, CH, Olivere, L, Comatas, K, Magnani, J, Kim Lyerly, H, Cheng, Q, McCall, CM, and Sipkins, DA. "Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone." Science translational medicine 8, no. 340 (May 2016): 340ra73

Das Roy, L, Zhou, R, Dillon, L, Moore, LJ, Puri, R, Marks, JR, Lyerly, HK, and Mukherjee, P. "Abstract P4-09-16: A monoclonal antibody with exceptional specificity across major breast cancer subtypes." February 15, 2016.

Kohrt, HE, Tumeh, PC, Benson, D, Bhardwaj, N, Brody, J, Formenti, S, Fox, BA, Galon, J, June, CH, Kalos, M, Kirsch, I, Kleen, T, Kroemer, G, Lanier, L, Levy, R, Lyerly, HK, Maecker, H, Marabelle, A, Melenhorst, J, Miller, J, Melero, I, Odunsi, K, Palucka, K, Peoples, G, Ribas, A, Robins, H, Robinson, W, Serafini, T, Sondel, P, Vivier, E, Weber, J, Wolchok, J, Zitvogel, L, Disis, ML, and Cheever, MA. "Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials." Journal for immunotherapy of cancer 4 (January 2016)

Wang, X, Ren, J, Zhang, J, Yan, Y, Jiang, N, Yu, J, Di, L, Song, G, Che, L, Jia, J, Zhou, X, Yang, H, and Lyerly, HK. "Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients

Oldham, M, Yoon, P, Fathi, Z, Beyer, WF, Adamson, J, Liu, L, Alcorta, D, Xia, W, Osada, T, Liu, C, Yang, XY, Dodd, RD, Herndon, JE, Meng, B, Kirsch, DG, Lyerly, HK, Dewhirst, MW, Fecci, P, Walder, H, and Spector, NL. "X-Ray Psoralen Activated Cancer Therapy (X-PACT)." PloS one 11, no. 9 (January 2016): e0162078-.